Effect of the simultaneous administration of glucocorticoids and IL-15 on human NK cell phenotype, proliferation and function

Cancer Immunology, Immunotherapy

Volumn 60, Issue 12, 2011, Pages 1683-1695

  Moustaki, Ardiana ^a   Argyropoulos, Kimon V ^a   Baxevanis, Constantin N ^a   Papamichail, Michael ^a   Perez, Sonia A ^a  

^a SAINT SAVVAS HOSPITAL   (Greece)

Author keywords

Apoptosis; Chemokine receptors; Glucocorticoids; IL 15; Natural killer cells; Proliferation

Indexed keywords

CD16 ANTIGEN; CD3 ANTIGEN; CD56 ANTIGEN; CD57 ANTIGEN; CD94 ANTIGEN; CHEMOKINE RECEPTOR CXCR1; CHEMOKINE RECEPTOR CXCR3; CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR7; DEXAMETHASONE; GAMMA INTERFERON; HYDROCORTISONE; INTERLEUKIN 15; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL1; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL3; L SELECTIN; LYMPHOCYTE RECEPTOR; METHYLPREDNISOLONE; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 2; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 3; NATURAL KILLER CELL RECEPTOR NKG2A; NATURAL KILLER CELL RECEPTOR NKG2D; PROTEIN 2B4; PROTEIN DNAM 1; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CELL DEATH; CELL DENSITY; CELL EXPANSION; CELL FUNCTION; CELL PROTECTION; CELL SURFACE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG MECHANISM; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; NATURAL KILLER CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; CELL PROLIFERATION; CELL SEPARATION; CELLS, CULTURED; DEXAMETHASONE; FLOW CYTOMETRY; GLUCOCORTICOIDS; HUMANS; IMMUNOPHENOTYPING; INTERLEUKIN-15; KILLER CELLS, NATURAL; METHYLPREDNISOLONE; MIDDLE AGED; PHENOTYPE;

EID: 82355169817     PISSN: 03407004     EISSN: 14320851     Source Type: Journal    
DOI: 10.1007/s00262-011-1067-6     Document Type: Article

References (51)

1. M Papamichail SA Perez AD Gritzapis CN Baxevanis 2004 Natural killer lymphocytes: biology, development, and function Cancer Immunol Immunother 53 176 186 14685782 10.1007/s00262-003-0478-4 (Pubitemid 38328040)
2. E Vivier E Tomasello M Baratin T Walzer S Ugolini 2008 Functions of natural killer cells Nat Immunol 9 503 510 18425107 10.1038/ni1582 1:CAS:528:DC%2BD1cXkvVOqu78%3D (Pubitemid 351560519)
3. SS Farag MA Caligiuri 2006 Human natural killer cell development and biology Blood Rev 20 123 137 16364519 10.1016/j.blre.2005.10.001 1:CAS:528:DC%2BD28Xlt1ejtL0%3D (Pubitemid 43786166)
4. JC Sun S Lopez-Verges CC Kim JL Derisi LL Lanier 2011 NK cells and immune "memory" J Immunol 186 1891 1897 21289313 10.4049/jimmunol.1003035 1:CAS:528:DC%2BC3MXhsVShur0%3D
5. MA Cooper TA Fehniger SC Turner KS Chen BA Ghaheri T Ghayur WE Carson MA Caligiuri 2001 Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset Blood 97 3146 3151 11342442 10.1182/blood.V97.10. 3146 1:CAS:528:DC%2BD3MXjsl2ru74%3D
6. A Chan DL Hong A Atzberger S Kollnberger AD Filer CD Buckley A McMichael T Enver P Bowness 2007 CD56bright human NK cells differentiate into CD56dim cells: role of contact with peripheral fibroblasts J Immunol 179 89 94 17579025 1:CAS:528:DC%2BD2sXmsF2nsrk%3D (Pubitemid 46986521)
7. NK Bjorkstrom P Riese F Heuts S Andersson C Fauriat MA Ivarsson AT Bjorklund M Flodstrom-Tullberg J Michaelsson ME Rottenberg CA Guzman HG Ljunggren KJ Malmberg 2010 Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education Blood 116 3853 3864 20696944 10.1182/blood-2010-04-281675
8. S Lopez-Verges JM Milush S Pandey VA York J Arakawa-Hoyt H Pircher PJ Norris DF Nixon LL Lanier 2010 CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subset Blood 116 3865 3874 20733159 10.1182/blood-2010-04-282301 1:CAS:528:DC%2BC3cXhsFahsbzO
9. S Arai HG Klingemann 2005 Natural killer cells: can they be useful as adoptive immunotherapy for cancer? Expert Opin Biol Ther 5 163 172 15757378 10.1517/14712598.5.2.163 1:CAS:528:DC%2BD2MXhsFSnurs%3D (Pubitemid 40388846)
10. JS Miller Y Soignier A Panoskaltsis-Mortari SA McNearney GH Yun SK Fautsch D McKenna C Le TE Defor LJ Burns PJ Orchard BR Blazar JE Wagner A Slungaard DJ Weisdorf IJ Okazaki PB McGlave 2005 Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer Blood 105 3051 3057 15632206 10.1182/blood-2004-07-2974 1:CAS:528: DC%2BD2MXjtlSmtb0%3D
11. JD Ashwell FW Lu MS Vacchio 2000 Glucocorticoids in T cell development and function, Annu Rev Immunol 18 309 345 10837061 10.1146/annurev.immunol.18.1. 309 1:CAS:528:DC%2BD3cXjs1Gmsbo%3D (Pubitemid 30365383)
12. GA Rook 1999 Glucocorticoids and immune function Baillieres Best Pract Res Clin Endocrinol Metab 13 567 581 10903815 10.1053/beem.1999.0044 1:STN:280:DC%2BD3czmtV2qtQ%3D%3D (Pubitemid 30315886)
13. JJ Cohen RC Duke 1984 Glucocorticoid activation of a calcium-dependent endonuclease in thymocyte nuclei leads to cell death J Immunol 132 38 42 6317746 1:CAS:528:DyaL2cXksFGqug%3D%3D (Pubitemid 14213827)
14. MJ Herold KG McPherson HM Reichardt 2006 Glucocorticoids in T cell apoptosis and function Cell Mol Life Sci 63 60 72 16314919 10.1007/s00018-005- 5390-y 1:CAS:528:DC%2BD28Xht1WjsL4%3D (Pubitemid 43100281)
15. CE Perandones VA Illera D Peckham LL Stunz RF Ashman 1993 Regulation of apoptosis in vitro in mature murine spleen T cells J Immunol 151 3521 3529 8376790 1:CAS:528:DyaK2cXivFartg%3D%3D (Pubitemid 23282664)
16. WY Almawi HN Beyhum AA Rahme MJ Rieder 1996 Regulation of cytokine and cytokine receptor expression by glucocorticoids J Leukoc Biol 60 563 572 8929546 1:CAS:528:DyaK28XntVCmt7k%3D (Pubitemid 26400412)
17. BN Cronstein SC Kimmel RI Levin F Martiniuk G Weissmann 1992 A mechanism for the antiinflammatory effects of corticosteroids: the glucocorticoid receptor regulates leukocyte adhesion to endothelial cells and expression of endothelial-leukocyte adhesion molecule 1 and intercellular adhesion molecule 1 Proc Natl Acad Sci USA 89 9991 9995 1279685 10.1073/pnas.89.21.9991 1:CAS:528:DyaK3sXhs1Giug%3D%3D
18. F Bischof A Melms 1998 Glucocorticoids inhibit CD40 ligand expression of peripheral CD4+ lymphocytes Cell Immunol 187 38 44 9682002 10.1006/cimm.1998. 1308 1:CAS:528:DyaK1cXltFSiur0%3D (Pubitemid 28359693)
19. E Baus F Andris PM Dubois J Urbain O Leo 1996 Dexamethasone inhibits the early steps of antigen receptor signalling in activated T lymphocytes J Immunol 156 4555 4561 8648096 1:CAS:528:DyaK28XjsFamtrc%3D (Pubitemid 26174433)
20. CM Zacharchuk M Mercep PK Chakraborti SS Simons Jr JD Ashwell 1990 Programmed T lymphocyte death. Cell activation- and steroid-induced pathways are mutually antagonistic J Immunol 145 4037 4045 1979585 1:STN:280: DyaK3M%2FnvFCrsA%3D%3D
21. D Franchimont J Galon MS Vacchio S Fan R Visconti DM Frucht V Geenen GP Chrousos JD Ashwell JJ O'Shea 2002 Positive effects of glucocorticoids on T cell function by up-regulation of IL-7 receptor alpha J Immunol 168 2212 2218 11859107 1:CAS:528:DC%2BD38XhvVehu7c%3D (Pubitemid 34171820)
22. GJ Wiegers MS Labeur IE Stec WE Klinkert F Holsboer JM Reul 1995 Glucocorticoids accelerate anti-T cell receptor-induced T cell growth J Immunol 155 1893 1902 7636240 1:CAS:528:DyaK2MXnsVSiurY%3D
23. CS Hinrichs DC Palmer SA Rosenberg NP Restifo 2005 Glucocorticoids do not inhibit antitumor activity of activated CD8+ T cells J Immunother 28 517 524 16224268 10.1097/01.cji.0000177999.95831.7b 1:CAS:528:DC%2BD2MXhtFSis73M (Pubitemid 41533084)
24. M Naito K Itoh N Komatsu Y Yamashita T Shirakusa A Yamada F Moriya H Ayatuka ER Mohamed K Matsuoka M Noguchi 2008 Dexamethasone did not suppress immune boosting by personalized peptide vaccination for advanced prostate cancer patients Prostate 68 1753 1762 18767041 10.1002/pros.20847 1:CAS:528: DC%2BD1MXlvVakug%3D%3D
25. SA Perez LG Mahaira FJ Demirtzoglou PA Sotiropoulou P Ioannidis EG Iliopoulou AD Gritzapis NN Sotiriadou CN Baxevanis M Papamichail 2005 A potential role for hydrocortisone in the positive regulation of IL-15-activated NK-cell proliferation and survival Blood 106 158 166 15755904 10.1182/blood-2004-08-3232 1:CAS:528:DC%2BD2MXlvVWjsLY%3D (Pubitemid 40967188)
26. EG Iliopoulou P Kountourakis MV Karamouzis D Doufexis A Ardavanis CN Baxevanis G Rigatos M Papamichail SA Perez 2010 A phase I trial of adoptive transfer of allogeneic natural killer cells in patients with advanced non-small cell lung cancer Cancer Immunol Immunother 59 1781 1789 20703455 10.1007/s00262-010-0904-3
27. M Salagianni E Lekka A Moustaki EG Iliopoulou CN Baxevanis M Papamichail SA Perez 2011 NK Cell adoptive transfer combined with ontak-mediated regulatory T cell elimination induces effective adaptive antitumor immune responses J Immunol 186 3327 3335 21317394 10.4049/jimmunol.1000652 1:CAS:528: DC%2BC3MXisl2qtr8%3D
28. BJ Quah HS Warren CR Parish 2007 Monitoring lymphocyte proliferation in vitro and in vivo with the intracellular fluorescent dye carboxyfluorescein diacetate succinimidyl ester Nat Protoc 2 2049 2056 17853860 10.1038/nprot.2007.296 1:CAS:528:DC%2BD2sXhtFagsb%2FL (Pubitemid 351565842)
29. H Lecoeur M Fevrier S Garcia Y Riviere ML Gougeon 2001 A novel flow cytometric assay for quantitation and multiparametric characterization of cell-mediated cytotoxicity J Immunol Methods 253 177 187 11384679 10.1016/S0022-1759(01)00359-3 1:CAS:528:DC%2BD3MXjvV2rsrk%3D (Pubitemid 32522525)
30. TA Fehniger MH Shah MJ Turner JB VanDeusen SP Whitman MA Cooper K Suzuki M Wechser F Goodsaid MA Caligiuri 1999 Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response J Immunol 162 4511 4520 10201989 1:CAS:528:DyaK1MXisFOms7Y%3D (Pubitemid 29314849)
31. C Vitale L Chiossone C Cantoni G Morreale F Cottalasso S Moretti A Pistorio R Haupt E Lanino G Dini L Moretta MC Mingari 2004 The corticosteroid-induced inhibitory effect on NK cell function reflects down-regulation and/or dysfunction of triggering receptors involved in natural cytotoxicity Eur J Immunol 34 3028 3038 15368269 10.1002/eji.200425418 1:CAS:528:DC%2BD2cXhtVWisrfO (Pubitemid 39549382)
32. L Chiossone C Vitale F Cottalasso S Moretti B Azzarone L Moretta MC Mingari 2007 Molecular analysis of the methylprednisolone-mediated inhibition of NK-cell function: evidence for different susceptibility of IL-2- versus IL-15-activated NK cells Blood 109 3767 3775 17234744 10.1182/blood-2006-07- 037846 1:CAS:528:DC%2BD2sXkvFCitL4%3D (Pubitemid 46641727)
33. LL Lanier 2008 Up on the tightrope: natural killer cell activation and inhibition Nat Immunol 9 495 502 18425106 10.1038/ni1581 1:CAS:528: DC%2BD1cXkvVOqu74%3D (Pubitemid 351560518)
34. A Moretta C Bottino M Vitale D Pende C Cantoni MC Mingari R Biassoni L Moretta 2001 Activating receptors and co receptors involved in human natural killer cell-mediated cytolysis Annu Rev Immunol 19 197 223 11244035 10.1146/annurev.immunol.19.1.197 1:CAS:528:DC%2BD3MXivFKgtbk%3D (Pubitemid 32368034)
35. C Romagnani K Juelke M Falco B Morandi A D'Agostino R Costa G Ratto G Forte P Carrega G Lui R Conte T Strowig A Moretta C Munz A Thiel L Moretta G Ferlazzo 2007 CD56brightCD16- killer Ig-like receptor- NK cells display longer telomeres and acquire features of CD56dim NK cells upon activation J Immunol 178 4947 4955 17404276 1:CAS:528:DC%2BD2sXjslWjsLc%3D (Pubitemid 46595277)
36. J Yu HC Mao M Wei T Hughes J Zhang IK Park S Liu S McClory G Marcucci R Trotta MA Caligiuri 2010 CD94 surface density identifies a functional intermediary between the CD56bright and CD56dim human NK-cell subsets Blood 115 274 281 19897577 10.1182/blood-2009-04-215491 1:CAS:528:DC%2BC3cXhtlKlsL0%3D
37. RD Berahovich NL Lai Z Wei LL Lanier TJ Schall 2006 Evidence for NK cell subsets based on chemokine receptor expression J Immunol 177 7833 7840 17114454 1:CAS:528:DC%2BD28Xht1WrsL3P (Pubitemid 44846299)
38. WE Carson TA Fehniger MA Caligiuri 1997 CD56bright natural killer cell subsets: characterization of distinct functional responses to interleukin-2 and the c-kit ligand Eur J Immunol 27 354 360 9045904 10.1002/eji.1830270203 1:CAS:528:DyaK2sXis1Gjs74%3D (Pubitemid 27085237)
39. MA Cooper TA Fehniger MA Caligiuri 2001 The biology of human natural killer-cell subsets Trends Immunol 22 633 640 11698225 10.1016/S1471-4906(01) 02060-9 1:CAS:528:DC%2BD3MXot1Siuro%3D (Pubitemid 33043908)
40. SA Perez PA Sotiropoulou DG Gkika LG Mahaira DK Niarchos AD Gritzapis YG Kavalakis AI Antsaklis CN Baxevanis M Papamichail 2003 A novel myeloid-like NK cell progenitor in human umbilical cord blood Blood 101 3444 3450 12506032 10.1182/blood-2002-05-1501 1:CAS:528:DC%2BD3sXjs1aqsL0%3D (Pubitemid 36857927)
41. SA Perez LG Mahaira PA Sotiropoulou AD Gritzapis EG Iliopoulou DK Niarchos NT Cacoullos YG Kavalakis AI Antsaklis NN Sotiriadou CN Baxevanis M Papamichail 2006 Effect of IL-21 on NK cells derived from different umbilical cord blood populations Int Immunol 18 49 58 16291655 10.1093/intimm/dxh348 1:CAS:528:DC%2BD28XitlShsQ%3D%3D (Pubitemid 43057036)
42. C Vitale F Cottalasso E Montaldo L Moretta MC Mingari 2008 Methylprednisolone induces preferential and rapid differentiation of CD34+ cord blood precursors toward NK cells Int Immunol 20 565 575 18310065 10.1093/intimm/dxn014 1:CAS:528:DC%2BD1cXjs1Witr0%3D (Pubitemid 351436192)
43. B Grzywacz N Kataria BR Blazar JS Miller MR Verneris 2011 Natural killer cell differentiation by myeloid progenitors Blood 117 3548 3558 21173117 10.1182/blood-2010-04-281394 1:CAS:528:DC%2BC3MXkslagtb8%3D
44. M Berg A Lundqvist P McCoy Jr L Samsel Y Fan A Tawab R Childs 2009 Clinical-grade ex vivo-expanded human natural killer cells up-regulate activating receptors and death receptor ligands and have enhanced cytolytic activity against tumor cells Cytotherapy 11 341 355 19308771 10.1080/14653240902807034 1:CAS:528:DC%2BD1MXlt1KmtLg%3D
45. S Huenecke SY Zimmermann S Kloess R Esser A Brinkmann L Tramsen M Koenig S Erben C Seidl T Tonn A Eggert A Schramm P Bader T Klingebiel T Lehrnbecher JR Passweg J Soerensen D Schwabe U Koehl 2010 IL-2-driven regulation of NK cell receptors with regard to the distribution of CD16+ and CD16- subpopulations and in vivo influence after haploidentical NK cell infusion J Immunother 33 200 210 20145545 10.1097/CJI.0b013e3181bb46f7 1:CAS:528:DC%2BC3cXitlWisro%3D
46. K Juelke M Killig M Luetke-Eversloh E Parente J Gruen B Morandi G Ferlazzo A Thiel I Schmitt-Knosalla C Romagnani 2010 CD62L expression identifies a unique subset of polyfunctional CD56dim NK cells Blood 116 1299 1307 20505160 10.1182/blood-2009-11-253286 1:CAS:528:DC%2BC3cXhtFersbbI
47. K Beider A Nagler O Wald S Franitza M Dagan-Berger H Wald H Giladi S Brocke J Hanna O Mandelboim M Darash-Yahana E Galun A Peled 2003 Involvement of CXCR4 and IL-2 in the homing and retention of human NK and NK T cells to the bone marrow and spleen of NOD/SCID mice Blood 102 1951 1958 12730102 10.1182/blood-2002-10-3293 1:CAS:528:DC%2BD3sXntlKkurg%3D (Pubitemid 37122366)
48. SJ Curnow K Wloka JM Faint N Amft CM Cheung V Savant J Lord AN Akbar CD Buckley PI Murray M Salmon 2004 Topical glucocorticoid therapy directly induces up-regulation of functional CXCR4 on primed T lymphocytes in the aqueous humor of patients with uveitis J Immunol 172 7154 7161 15153539 1:CAS:528: DC%2BD2cXktFSku7g%3D (Pubitemid 38669159)
49. M Wendel IE Galani E Suri-Payer A Cerwenka 2008 Natural killer cell accumulation in tumors is dependent on IFN-gamma and CXCR3 ligands Cancer Res 68 8437 8445 18922917 10.1158/0008-5472.CAN-08-1440 1:CAS:528:DC%2BD1cXht1CmsbrP
50. JA Burger TJ Kipps 2006 CXCR4: a key receptor in the crosstalk between tumour cells and their microenvironment Blood 107 1761 1767 16269611 10.1182/blood-2005-08-3182 1:CAS:528:DC%2BD28XitFChsLo%3D (Pubitemid 43289351)
51. V Muller C Alix-Panabieres K Pantel 2010 Insights into minimal residual disease in cancer patients: implications for anti-cancer therapies Eur J Cancer 46 1189 1197 20347588 10.1016/j.ejca.2010.02.038